flecha

Product

flecha
Osseor®
Osseor®, whose main active ingredient is strontium ranelate, is aimed at the treatment of postmenopausal osteoporosis in order to decrease the risk of spinal or hip fractures.
Osseor®, whose main active ingredient is strontium ranelate, is aimed at the treatment of postmenopausal osteoporosis in order to decrease the risk of spinal or hip fractures. One of its differentiating characteristics is its way of acting, encouraging bone formation and preventing its degeneration. It is the result of research at Les Laboratoires Servier and has been marketed by ROVI since 2005.
 
Link More information
 
Permalink  
Delicious  Technorati  Facebook  Twitter  Meneame 
Search
linea
Google Custom Search
BioRegión Collaborative Area
BioRegión Collaborative Area
RSS
linea
RSS RSS Andalucía BioRegión
User Acces
linea
Email:
Password:

Register

Forgot your password?

Companies/centers Acces
line
Email:
Password:

Register your company

Forgot your password?

Tag cloud
line
View more tags
BioRegión Collaborative Area